| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-14 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |